Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26.
HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20 million from strategic partner Medtronic and additional investments by life sciences fund RTW.
Health Sciences 2 had about $67.7 million in its trust going into the vote after seeing 57.7% of shares redeemed in an earlier extension. Proceeds nonetheless exceeded the the transaction’s $60 million minimum cash condition.
The combined company will commence trading today on the Nasdaq under the symbol “OBIO”. Health Sciences 2 did not include warrants in its units when it IPO’d in August 2020.
The parties announced their $158 million deal with Orchestra BioMed in July 2022. New Hope, Pennsylvania-based Orchestra BioMed develops evidence-based therapeutic solutions for medical procedures that address major medical conditions, with a particular focus on cardiovascular diseases.
ADVISORS
- Jefferies LLC and Piper Sandler & Co. acted as Joint Lead Placement Agents for the Series D Financing
- Aegis Capital acted as Selling Agent.
- Jefferies LLC is acting as lead financial advisor and a capital markets advisor to Orchestra BioMed.
- Piper Sandler & Co. is acting as strategic advisor to Orchestra BioMed
- Piper Sandler & Co. is acting as a capital markets advisor to Orchestra BioMed.
- Chardan Capital Markets LLC is serving as financial and capital markets advisor to HSAC2
- Barclays Capital Inc. is serving as financial and capital markets advisor to HSAC2.
- Paul Hastings LLP is serving as legal counsel for Orchestra BioMed. Loeb & Loeb LLP is serving as legal counsel for HSAC2.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) has filed for a $150 million SPAC to hunt for a consumer target in a developed market. Investors in the new SPAC will get a 1/2 warrant in each unit and its trust is not overfunded. But, Vendome I may potentially have a sooner redemption event than most recently issued...
Timber Road Acquisition Corp. (NASDAQ:TMRDU) has filed for a $200 million SPAC to put its team’s real estate investing experience to work as it conducts a broad search for a target. The new SPAC is to include one right to a 1/8 share in each unit and is underwritten by Roth Capital Partners. It becomes Roth’s...
At the SPAC of Dawn Votes are beginning to come in as the market returns to normal business, and four SPACs still have four more special meetings on the docket for extensions this week. TLGY (OTC:TLGYF) is set to have its meeting at 9 am ET today and it primed the pump with a letter...
Gores Holdings X, Inc. (NASDAQ:GTENU) has filed for a $260 million SPAC to continue building the consistent track record of the Gores team. This is to be the team’s first outing with Santander as its underwriter after all 15 previous Gores SPACs were underwritten by Deutsche Bank. Of these, 14 made it to an IPO...
Ares Acquisition Corporation II (NYSE:AACT) has entered into a definitive agreement to combine with autonomous trucking firm Kodiak at a pro forma enterprise value of $2.67 billion. Mountain View, California-based Kodiak has developed driverless heavy truck technology for the industrial, logistics and defense sectors. Transaction Overview Ares II has an estimated $556 million in trust...